Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40005651
Localisation
France
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
15/01/2026
Statut
Classification
1.5°C
Année cible
2032
Near-Term Targets: ProductLife Group commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by 2032 from a 2024 base year. ProductLife Group also commits to reduce scope 3 GHG emissions from fuel- and energy-related activities, waste generated in operations, business travel, employee commuting and upstream leased assets 58.14% per EUR value added within the same timeframe. ProductLife Group further commits that 67.0% of its suppliers by spend covering purchased goods and services and capital goods, will have science-based targets by 2030.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques